Mutation in several constituents of the mTORC1 pathway can give rise to oncogenes, thereby promoting the pathway (i.e. PI3K, AKT) or inactivate tumor suppressors like PTEN which usually inhibit the pathway [114, 115]. The gene discussed is PTEN; the disease is neoplasm.